Archives of Internal Medicine · 2004 · 408 citations · 14 references
Life SciencesPhysiologyExercise PhysiologyHealth-related FitnessPhysical ActivityCardiorespiratory FitnessCardiovascular DiseaseMetabolic SyndromePhysical FitnessAlcohol Consumption PatternsCardiovascular Disease IncidenceCardiovascular Disease MortalityCardiovascular Fitness AssessmentCardiovascular Fitness TestingClinical Cardiorespiratory FitnessHealth-related Physical FitnessMetabolic Syndrome Epidemiology
Metabolic syndrome is common and increases the risk of type 2 diabetes, cardiovascular disease, and mortality. The study aimed to assess how cardiorespiratory fitness influences mortality among healthy men and those with metabolic syndrome. Researchers followed 19,223 men aged 20–83 from 1979–1995, classifying 80.5 % as healthy and 19.5 % as having metabolic syndrome, and tracked deaths through 1996. In this cohort, men with metabolic syndrome had higher all‑cause (RR 1.29) and CVD (RR 1.89) mortality, but cardiorespiratory fitness attenuated these risks, with unfit men showing 2‑to‑3‑fold higher mortality and a dose‑response protective effect of fitness observed in both healthy and metabolic‑syndrome groups.
<h3>Background</h3> The metabolic syndrome is a prevalent condition that carries with it an increased risk of type 2 diabetes mellitus, cardiovascular disease (CVD), and mortality. <h3>Objective</h3> To determine the relationship between cardiorespiratory fitness (CRF) and mortality in healthy men and in those with the metabolic syndrome. <h3>Methods</h3> The sample included 19 223 men, aged 20 to 83 years, who received a clinical evaluation between 1979 and 1995 with mortality follow-up through December 31, 1996. There were 15 466 healthy men (80.5%) and 3757 men with the metabolic syndrome (19.5%). <h3>Results</h3> A total of 480 deaths (161 due to CVD) occurred during 196 298 man-years of follow-up. After adjustment for age, year of examination, smoking status, alcohol consumption, and parental CVD, the relative risks (RRs) (95% confidence interval) of all-cause and CVD mortality were 1.29 (1.05-1.57) and 1.89 (1.36-2.60), respectively, for men with the metabolic syndrome compared with healthy men. After the inclusion of CRF, the associations were not significant. The RRs comparing unfit with fit men for all-cause mortality were 2.18 (1.66-2.87) in healthy men and 2.01 (1.38-2.93) in men with the metabolic syndrome, whereas the RRs for CVD mortality for unfit vs fit men were 3.21 (2.03-5.07) in healthy men and 2.25 (1.27-3.97) in men with the metabolic syndrome. A significant dose-response relationship between CRF and mortality was also observed in men with the metabolic syndrome. <h3>Conclusion</h3> In this sample, CRF provided a strong protective effect against all-cause and CVD mortality in healthy men and men with the metabolic syndrome.
14
Scott M. Grundy · JAMA · 1993 · 27.9K citations
K. G. M. M. Alberti, Paul Zimmet · Diabetic Medicine · 1998 · 15.3K citations
Prevalence of the Metabolic Syndrome Among US Adults
Earl S. Ford, Wayne H. Giles, William H. Dietz · JAMA · 2002 · 6.7K citations